US 7,064,195 B2Granted

Fusion proteins of mycobacterium tuberculosis antigens and their uses

AssigneeCorixa Corporation

InventorsYasir Skeiky, Mark Alderson, Antonio Campos-Neto

Life of this patent

Estimating the term…

Abstract

The present invention relates to fusion proteins of Mycobacterium tuberculosis antigens. In particular, it relates to two fusion proteins, each of which contains three individual M. tuberculosis antigens, and a fusion protein of two M. tuberculosis antigens, their coding sequences, and methods for their use in the treatment and prevention of tuberculosis.

Claims9

Dependent claims

An isolated polynucleotide that encodes a polypeptide comprising the amino acid sequence of SEQ ID NO:2.

Dependencies are inferred from the claim text.

Facts

Application: 10/359,459Filed 5 Feb 2003 · continuation
Priority: 30 Dec 1998
Published: US 2004/0013677 A122 Jan 2004
Granted: 20 Jun 2006
Term ends: Not estimatedThe source records don’t support an estimate.

Classification9 codes

C07K 14/35
From bacteria: from Mycobacteriaceae
A61P 31/04
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics: antibacterial agents
A61P 31/06
Antibacterial agents: for tuberculosis
A61K 38/00
Medicinal preparations containing peptides

Family

Application09/223,040Parent of this continuation · filed 30 Dec 1998
US 2004/0013677 A1Pre-grant publication · published 22 Jan 2004
US 6,544,522 B1Parent of this continuation
US 7,064,195 B2This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results